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Abstract. Carbohydrate counting is an important meal-planning tool for patients on intensive insulin regimens. Preprandial insulin
bolus is adjusted taking into account the carbohydrate content of each meal and the insulin-to-carb ratio of each patient throughout
the day. Evidence suggests that accurate carbohydrate counting may have positive effects not only on reducing glycosylated
hemoglobin concentration but also on decreasing the incidence of hypoglycemic episodes. Nevertheless, despite its benefits, the
efficacy of carbohydrate counting depends on the ability of each patient, or its caregiver, to accurately estimate the carbohydrate
content of each meal. Therefore, it is of great importance to understand how accurate should carbohydrate counting be, and the
impact of inaccurate carbohydrate counting on the glycemic control of each patient. Within this work, we propose an analytic
method that uses the insulin-to-carb ratio and the insulin sensitivity factor, along with the glycemic targets of each patient to
calculate the limits of accurate carbohydrate counting, in order to achieve better glycemic control and to reduce hypoglycemic
episodes.
INTRODUCTION
Evidence suggests that diet has an important role in diabetes prevention and management. Indeed, patients on
intensive insulin regimens widely use diet planning along with carbohydrate counting to control postprandial glycemia
[1, 2, 3]. Furthermore, the accuracy of carbohydrate counting is determinant to avoid postprandial hypoglycemic and
hyperglycemic episodes [2]. Smart et al showed that a variation of about 20 g, above or below a planed meal containing
60 g of carbohydrates, may result in postprandial hyperglycemia or hypoglycemia, respectively [4]. However, a
variation of about 10 g in carbohydrate estimation should not have a considerable effect on the postprandial glycemia
[5]. Although these limits provide some guidance to those using intensive insulin therapy, they need to be improved.
To that end, we propose an analytic method to find the limit to carbohydrate counting error according to each person
insulin-to-carb ratio and the insulin sensitivity factor.
MATHEMATICAL METHODS
The insulin bolus for each meal can be calculated using the following equation:
B =
(CHO
ICR
+
G −GT
IS F
)
K − IOB, (1)
where B is the bolus, CHO are the carbohydrates planned to be consumed in that meal, ICR is the insulin-to-carb ratio
(n.b., ICR > 0), G is the pre-meal blood glucose, GT is the pre-meal blood glucose target, IS F is the insulin sensitivity
factor (n.b., IS F > 0), K is a constant reflecting the physiologic status of the patient, and IOB (Insulin-on-Board) is
the insulin remaining active from the previously administrated bolus [6, 7]. In the following analysis, we will consider
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K = 1 (i.e., the influence of illness, physical activity or medication on insulin and glucose metabolism of patients
is not addressed in this study) and IOB = 0 (i.e., the time between meals is higher than the duration of insulin
action, and there is no insulin stacking). Furthermore, we also consider that patient’s ICR and IS F are physiologically
appropriate.
Let CHO = ˆCHO ± ΔCHO be a variable of Equation 2, where ˆCHO is an estimate of CHO with an absolute
error ΔCHO > 0, and the other variables of Equation 2 are exact values. So, the absolute error on B is equal to
ΔB =
∣∣∣B − Bˆ∣∣∣, where: B = CHO/ICR + (G −GT )/IS F and Bˆ = ˆCHO/ICR + (G −GT )/IS F. Therefore, we have:
ΔB =
∣∣∣∣∣∣
CHO − ˆCHO
ICR
∣∣∣∣∣∣ =
ΔCHO
ICR
. (2)
The absolute error of B, given by Equation 2, will act as an undesired correction bolus, and its effect on the
patient blood glucose is:
ΔG = ΔB · IS F = IS F
ICR
ΔCHO,
where ΔG is the variation on the patient postprandial blood glucose, as a result of ΔCHO. By denoting the
hyperglycemia and hypoglycemia limits as GHyper and GHypo, respectively, it is possible to conclude that the maximum
value of ΔG allowed to avoid hyperglycemia and hypoglycemia episodes is given by min
{
GHyper −GT ,GT −GHypo
}
1
and, therefore, the maximum value of ΔCHO, i.e., ΔCHOmax, is given by:
ΔCHOmax =
ICR
IS F
·min
{
GHyper −GT ,GT −GHypo
}
. (3)
By using Equation 3, it is possible to find personalized limits of accurate carbohydrate counting according to each
patient data. Such tailored limits may have a decisive influence in order to achieve better glycemic control, reducing
the frequency of hyperglycemia and hypoglycemia episodes and glycemic variability.
DISCUSSION
Several studies show that patients with diabetes underestimate carbohydrate counting fearing hypoglycemic episodes,
as a consequence, they have high levels of HbA1C [8, 9]. Nevertheless, such worrying could be relieved if patients are
aware of their limits. For this purpose, we can use Equation 3, where the maximum admissible absolute error while
counting carbohydrates depends on the ICR, the IS F, and the glycemic targets of each patient. To assess the proposed
method, we will consider a hypothetical patient of 75 kg body weight, taking a total of 50U of insulin per day, having
the following glycemic targets, GHyper = 150mg/dL, GHypo = 70mg/dL, and GT = 110mg/dL. Regarding the ICR
and IS F values for that patient, they were obtained using the rules reported by King et al in [10] and by Grunberger et
al in [11], as presented in Table 1 and pictured in Figure 1.
By using Equation 3 to calculate the maximum admissible absolute error that our hypothetical patient can commit
while counting carbohydrates, and considering the arithmetic means of ICR and IS F found in Table 1, one find the
value of:
ΔCHOmax ≈ 8.3334.14 ·min {150 − 110, 110 − 70} ≈ 9.76 g.
Therefore, according to the method proposed in this work, it is reasonable to argue that the maximum absolute
error that our hypothetical patient can commit while estimating the carbohydrate content of each meal is approximately
10 g. This result corroborate the findings presented in [4, 5] by Smart et al for a pediatric population, and also with
the results presented in [9, 12] for an adult population with T1DM. For patients with T2DM, the limits for accurate
carbohydrate counting could be more permissive as demonstrated in Figure 1, since they have lower IS F values due
to insulin resistance.
1The function min{·} returns the minimum value of a set of elements.
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TABLE 1. The maximum admissible absolute error while counting carbohydrates, i.e., ΔCHOmax, for different
values of ICR and IS F according to the rules reported in [10, 11].
ICR rule ICR (g/U) IS F rule IS F (mg/dL/U) ΔCHOmax (g)
(2.8 × BW lb)/TDD 9.26 1724/TDD 34.48 10.74
441/TDD 8.82 1694/TDD 33.88 10.41
(2.8 × BW lb)/TDD 9.26 1694/TDD 33.88 10.93
(2.6 × BW lb)/TDD 8.60 1960/TDD 39.20 8.77
(217/TDD) + 3 7.34 (1076/TDD) + 12 33.52 8.76
300/TDD 6.00 1500/TDD 30.00 8.00
450/TDD 9.00 1700/TDD 34.00 10.59
Arithmetic mean: 8.33 34.14
Note:
TDD is the Total Daily Dose of insulin, BW is the patient body weight, and U means units of insulin.
To calculate ICR, IS F, and ΔCHOmax were used the following values:
TDD = 50U, BW = 75 kg, GHyper = 150mg/dL, GHypo = 70mg/dL, and GT = 110mg/dL.
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FIGURE 1. The maximum admissible absolute error while counting carbohydrates, i.e., ΔCHOmax, as a function of ICR/IS F.
CONCLUSION
Carbohydrate counting is a well established meal-planing approach used by patients on intensive insulin regimens to
improve their glycemic control. Such patients adjust their preprandial insulin bolus taking into account an estimate of
the carbohydrate content of each meal. Evidence suggests that the accuracy of such estimate is vital to reduce glycemic
variability and avoid hyper and hypoglycemic episodes. Indeed, several studies brought to light some limits to accurate
carbohydrate counting. Although such limits give important guidance to those using intensive insulin regimens, they
need to be improved and better understood by each patient. To that end, this work proposed a new analytic method
that uses personalized data (i.e., the insulin-to-carb ratio, the insulin sensitivity factor, and the glycemic targets of each
patient) to find the maximum absolute error that each patient can commit while estimating the carbohydrate content of
each meal. The proposed method was assessed using data from the literature and the results obtained are in line with
the most recent outcomes. Therefore, the proposed method allows patients with T1DM to be more confident when
using carbohydrate counting, as they are aware of their limits. For those with T2DM, or having insulin resistance,
the absolute error performed when counting carbohydrates could be higher and the risk of hypoglycemic events is
reduced when compared with T1DM patients.
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